Trial protocols and selective reporting at The Lancet

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1648, 2008-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective Reporting, Publication Bias and Clinical Trial Registry: An Industry Perspective

By Berlin Jesse A.

International Journal of Pharmaceutical Medicine, Vol. 19, Iss. 5-6, 2005-01 ,pp. : 277-284

Adis International

Access to resources Recommend Favorite

UKPRI "a missed opportunity": Lancet editorial

Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

UKPRI "a missed opportunity": Lancet editorial

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 566, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Selective endothelin receptor blockade in resistant hypertension: results of the DORADO trial

By Grassi Guido

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 1, 2011-01 ,pp. : 153-155

Informa Healthcare

Access to resources Recommend Favorite

Comparison of Reporting of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Selective COX-2 Inhibitors

By Lois La Grenade Lee Lauren Weaver Joyce Bonnel Renan Karwoski Claudia Governale Laura Brinker Allen

Drug Safety, Vol. 28, Iss. 10, 2005-01 ,pp. : 917-924

Adis International

Access to resources Recommend Favorite